To repeal Public Law 114-145 to ensure that the Drug Enforcement Administration has the authority to carry out needed enforcement actions for drug diversion control investigations and operations to combat the opioid epidemic.
USA115th CongressHR-4079| House
| Updated: 11/1/2017
Brian K. Fitzpatrick
Republican Representative
Pennsylvania
Cosponsors (15)
Joe Courtney (Democratic)Katherine M. Clark (Democratic)Collin C. Peterson (Democratic)Ann M. Kuster (Democratic)Stephen F. Lynch (Democratic)Kyrsten Sinema (Independent)Timothy J. Walz (Democratic)Betty McCollum (Democratic)Tulsi Gabbard (Democratic)William R. Keating (Democratic)Evan H. Jenkins (Republican)Zoe Lofgren (Democratic)Harold Rogers (Republican)Ted Budd (Republican)Barbara Comstock (Republican)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Restoring Enforcement Standards to Track Opioids Responsively and Effectively Act of 2017 or the RESTORE Act of 2017 This bill repeals the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. Provisions of the Controlled Substances Act amended by the Act are restored.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Crime and Law Enforcement
Administrative remediesCongressional oversightCrime preventionCriminal investigation, prosecution, interrogationDepartment of JusticeDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsHealth care coverage and accessLicensing and registrationsMedical educationPrescription drugsRetail and wholesale trades
To repeal Public Law 114-145 to ensure that the Drug Enforcement Administration has the authority to carry out needed enforcement actions for drug diversion control investigations and operations to combat the opioid epidemic.
USA115th CongressHR-4079| House
| Updated: 11/1/2017
Restoring Enforcement Standards to Track Opioids Responsively and Effectively Act of 2017 or the RESTORE Act of 2017 This bill repeals the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. Provisions of the Controlled Substances Act amended by the Act are restored.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Brian K. Fitzpatrick
Republican Representative
Pennsylvania
Cosponsors (15)
Joe Courtney (Democratic)Katherine M. Clark (Democratic)Collin C. Peterson (Democratic)Ann M. Kuster (Democratic)Stephen F. Lynch (Democratic)Kyrsten Sinema (Independent)Timothy J. Walz (Democratic)Betty McCollum (Democratic)Tulsi Gabbard (Democratic)William R. Keating (Democratic)Evan H. Jenkins (Republican)Zoe Lofgren (Democratic)Harold Rogers (Republican)Ted Budd (Republican)Barbara Comstock (Republican)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
Crime and Law Enforcement
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative remediesCongressional oversightCrime preventionCriminal investigation, prosecution, interrogationDepartment of JusticeDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsHealth care coverage and accessLicensing and registrationsMedical educationPrescription drugsRetail and wholesale trades